PPARA and neoplasm: In the scope of this review, we explored the effects and possible mechanisms of PPAR agonists in tumourigenesis and the tumour microenvironment (TME), we also analysed the latest evidence on the co‐administration of PPAR agonists with chemo, immune or other therapies and conducted a critical assessment of the existing knowledge gaps and progress in this area.